Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
-1.01 %
$ 42.2 M
Market Cap
-2.2
P/E
LTRN - OTHER CURRENT LIABILITIES
Other Current Liabilities LTRN - Lantern Pharma Inc.
2.51 M
LAST VALUE
29.54%
2 YEAR CAGR
35.23%
5 YEAR CAGR
0.00%
10 YEAR CAGR